Canurta stands at the forefront of biotechnological innovation, developing new small-molecule therapeutics from rare botanicals to address critical unmet needs across neurology, virology, oncology, and immunology. Leveraging the distinctive properties of cannflavins A and B, it is not only pushing the boundaries in disease treatment and prevention but also demonstrating first-in-class and best-in-class potential in our pipeline assets. Its mission goes beyond mere innovation; it’s about significantly improving health outcomes worldwide. By developing effective therapies for both chronic and emerging health challenges, Canurta is not just contributing to the global healthcare conversation but is poised to solidify Canada’s esteemed position in the global innovation and healthcare sectors.

Canurta logo



Event details

Date: January 8 - 10, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


18 in total